Company Filing History:
1 out of 20 
1 out of 237 
1 out of 61 
Years Active: 2019
Title: Daniel Schumperli: Innovator in Antisense Oligonucleotide Technology
Introduction
Daniel Schumperli is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides. His innovative work focuses on therapeutic applications for various genetic diseases.
Latest Patents
Daniel Schumperli holds a patent for "Tricyclo-DNA antisense oligonucleotides, compositions, and methods for the treatment of disease." This patent describes tricyclo-DNA (tc-DNA) AON and methods for modifying splicing events during pre-mRNA processing. The tc-DNA AON can facilitate exon skipping or mask intronic silencer sequences during pre-mRNA processing. This technology has potential applications in treating Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, and Steinert's Myotonic Dystrophy.
Career Highlights
Throughout his career, Daniel Schumperli has worked with prestigious organizations such as the Association Institut De Myologie and Sorbonne Université. His research has focused on advancing the understanding and treatment of genetic disorders through innovative molecular techniques.
Collaborations
Daniel has collaborated with notable colleagues, including Christian Leumann and Denis Furling. These partnerships have contributed to the advancement of his research and the development of new therapeutic strategies.
Conclusion
Daniel Schumperli's work in the field of antisense oligonucleotides represents a significant advancement in genetic therapy. His innovative approaches have the potential to transform the treatment landscape for various genetic diseases.